Welcome to the investors section of Adocia
Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.
- 2020/02/06Number of shares and voting rights of ADOCIA as of January 31, 2019
- 2020/01/10Half year report on Adocia’s liquidity agreement with Kepler Capital Markets
- 23-25 March, 2020 BIO-Europe Spring, Paris, France - The Europe's Largest Springtime Biotech Partnering Event